Skip to main content
SpringerLink
Log in

Lipid and glucide sources in artificial nutrition

  • Review
  • Published:
Mediterranean Journal of Nutrition and Metabolism

Abstract

Lipids and glucides, the energetic compounds in artificial nutrition solutions, are not only “fuel” but possess other biologic functions which may influence disease evolution. Energy-yielding solutions should cover the patient’s metabolic needs but should also limit any inflammatory and oxidative stress or impairment of the immune system. This paper provides a concise overview of the clinical and metabolic properties of the most common energetic substrates employed both in enteral and parenteral nutrition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stapleton RD, Jones N, Heyland DK (2007) Feeding critically ill patients: what is the optimal amount of energy? Crit Care Med 35:S535–S540

    Article  Google Scholar 

  2. Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367

    Article  Google Scholar 

  3. Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290:2041–2047

    Article  CAS  Google Scholar 

  4. Van den Berghe G, Wilmer A, Milants I et al (2006) Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55:3151–3159

    Article  CAS  Google Scholar 

  5. Garber AJ, Moghissi ES, Bransome ED Jr et al (2004) American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10:77–82

    Google Scholar 

  6. Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139

    Article  CAS  Google Scholar 

  7. Wiener S, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300:933–944

    Article  CAS  Google Scholar 

  8. Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327

    Article  Google Scholar 

  9. Wahed M, Geoghenan M, Powel-Tuck J (2007) Novel substrates. Eur J Gastroenterol Hepatol 19:365–370

    Article  CAS  Google Scholar 

  10. Elia M, Engfer M, Green C, Silk D (2008) Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther 27:120–145

    Article  CAS  Google Scholar 

  11. Elia M, Ceriello A, Laube H (2005) Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes. A systematic review and meta-analysis. Diabetes Care 28:2267–2279

    Article  Google Scholar 

  12. American Diabetes Association (2008) Nutrition Recommendations and Intervention for Diabetes. A position statement of the American Diabetes Association. Diabetes Care 31:S61–S78

    Article  CAS  Google Scholar 

  13. Volman J, Ramakers J, Plat J (2008) Dietary modulation of immune function by β-glucans. Physiol Behav 94:276–284

    Article  CAS  Google Scholar 

  14. Wanten GJ, Calder P (2007) Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 85:1171–1184

    CAS  Google Scholar 

  15. Driscol DF (2006) Lipid injectable emulsions: 2006. Nutr Clin Pract 21:381–386

    Article  Google Scholar 

  16. Wanten G (2006) An update on parenteral lipids and immune function: only smoke, or is there any fire? Curr Opin Clin Nutr Metab Care 9:79–83

    Article  CAS  Google Scholar 

  17. Wirtitsch M, Wessner B, Spittler A et al (2007) Effect of different lipid emulsions on the immunological function in humans: a systematic review with meta-analysis. Clin Nutr 26:302–313

    Article  CAS  Google Scholar 

  18. Furukawa K, Yamamori H, Takagi K et al (2002) Influences of soy bean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition 18:235–240

    Article  CAS  Google Scholar 

  19. Heyland DK (2000) Parenteral nutrition in critically ill patients: more harm that good. Proc Nutr Soc 59:457–466

    CAS  Google Scholar 

  20. Oliveira FL, Rumsey SC, Schlotzer E et al (1997) Triglyceride hydrolysis of soy oil vs fish oil emulsions. JPEN J Parenter Enteral Nutr 21:224–229

    Article  CAS  Google Scholar 

  21. Wanten GJ, Naber AH (2004) Cellular and physiological effects of medium-chain triglycerides. Mini Rev Med Chem 4:847–857

    CAS  Google Scholar 

  22. Van den Berghe G, Wouters P, Weekers F (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367

    Article  Google Scholar 

  23. Sukkar SG, Cella F, Magliano A et al (2006) Medium-term parenteral nutrition (MTPN) with medium/long-chain triglycerides (MCT/LCT) in malnourished patients: effects on nutritional and metabolic parameters. Nutr Ther Metab 24:134–139

    Google Scholar 

  24. Waitzberg DL, Torrinhas RS, Jacintho TM (2006) New parenteral lipid emulsions for clinical use. JPEN J Parenter Enteral Nutr 30:351–367

    Article  CAS  Google Scholar 

  25. Chambrier C, Lauverjat M, Bouletreau P (2006) Structured triglyceride emulsions in parenteral nutrition. Nutr Clin Pract 21:342–350

    Article  CAS  Google Scholar 

  26. Reimund JM, Rahmi G, Escalin G et al (2005) Efficacy and safety of an olive oil-based intravenous fat emulsion in adult patients on home parenteral nutrition. Aliment Pharmacol Ther 21:445–454

    Article  CAS  Google Scholar 

  27. Kelbel I, Wagner F, Wiedeck-Suger H et al (2003) Effects of n-3 fatty acids on immune function: a double blind, randomized trial of fish-oil based infusion in post-operative patients. Clin Nutr 22:59–64

    Article  CAS  Google Scholar 

  28. Grimm H, Mertes N, Goeters C et al (2006) Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 45:55–60

    Article  CAS  Google Scholar 

  29. Mertes N, Grimm H, Furst P et al (2006) Safety and efficacy of a new parenteral lipid emulsion (SMOFLipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 50:253–259

    Article  CAS  Google Scholar 

  30. Zachos M, Tondeur M, Griffiths AM (2007) Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev: CD000542

  31. Mayer K, Seeger W (2008) Fish oil in critical illness. Curr Opin Clin Nutr Metab Care 11:121–127

    Article  CAS  Google Scholar 

  32. Wild GE, Drozdowski L, Tartaglia C et al (2007) Nutritional modulation of the inflammatory response in inflammatory bowel disease: from the molecular to the integrative to the clinical. World J Gastroenterol 13:1–7

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UOS Nutrizione Clinica e Dietologia, AO San Carlo Borromeo, Via Pio II no. 3, 20153, Milan, Italy

    Donatella Noè, Paola Lanzi & Elisabetta Bergamaschi

Authors
  1. Donatella Noè
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Lanzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisabetta Bergamaschi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donatella Noè.

About this article

Cite this article

Noè, D., Lanzi, P. & Bergamaschi, E. Lipid and glucide sources in artificial nutrition. Mediterr J Nutr Metab 3, 9–14 (2010). https://doi.org/10.1007/s12349-009-0064-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12349-009-0064-1

Keywords

Search

Navigation